Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR-/- mice

Alcoholism: Clinical and Experimental Research

Volumn 34, Issue 9, 2010, Pages 1535-1542

  Leckey, Leslie C ^a   Garige, Mamatha ^b   Varatharajalu, Ravi ^b   Gong, Maokai ^b   Nagata, Takako ^b   Spurney, Christopher F ^c   Lakshman, Raj M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Ethanol; LDLR Mouse; Paraoxonase; Quercetin

Indexed keywords

ALCOHOL; ARYLDIALKYLPHOSPHATASE 1; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; BIOMICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PON1 GENE; PRIORITY JOURNAL; WINE;

ANIMALS; AORTA; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ETHANOL; GENE EXPRESSION; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; QUERCETIN; RECEPTORS, LDL; UP-REGULATION;

MUS;

EID: 77956052985     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2010.01238.x     Document Type: Article

References (31)

1. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billicke S, Draganov D, Rosenblat M (2000) Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxide-like activities. Circulation 101 : 2510 2517.
2. Aviram M, Rosenblat M (2004) Paraoxonases 1, 2, 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37 : 1304 1316.
3. Aviram M, Rosenblat M, Billeke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum PON is inactivated by oxidized LDL and preserved by antioxidants. Free Radic Biol Med 26 : 892 904.
4. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101 : 1581 1590.
5. Aviram M, Volkova N, Coleman R, Dreher M, Reddy MK, Ferreira D, Rosenblat M (2008) Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein e-deficient (E0) mice and in vitro in cultured macrophages and lipoproteins. J Agric Food Chem 56 : 1148 1157.
6. de Boer VC, Dihal AA, van der Woude H, Arts IC, Wolffram S, Alink GM, Rietjens IM, Keijer J, Hollman PC (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135 (7 1718 1725.
7. Daugherty A (2002) Mouse models of atherosclerosis. Am J Med Sci 323 (1 3 10.
8. Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21 (4 473 480.
9. Fitzgerald S, Gan L, Wickman-Tordby A, Bergström G (2003) Cardiovascular and renal phenotyping of genetically modified mice - a challenge for traditional physiology. Clin Exp Pharmacol Physiol 30 : 207 216.
10. Fuhrman B, Aviram M (2002) Preservation of paraoxonase activity by wine flavonoids: possible roles in protection of LDL from lipid peroxidation. Ann NY Acad Sci 957 : 321 324.
11. van der Gaag MS, van Tol A, Scheek LM, James RW, Urgert R, Schaafsma G, Hendriks HF (1999) Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomized intervention study in middle-aged men. Atherosclerosis 147 : 405 410.
12. Gan LM, Grönros J, Hägg U, Wikström J, Theodoropoulos C, Friberg P, Fritsche-Danielson R (2007) Non-invasive real-time imaging of atherosclerosis in mice using ultrasound biomicroscopy. Atherosclerosis 190 (2 313 320.
13. Gong M, Garige M, Varatharajalu R, Marmillot P, Gottipati C, Leckey LC, Lakshman MR (2009) Quercetin up regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun 379 : 1001 1004.
14. Jakubowski H (2000) Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase. J Biol Chem 275 : 3957 3962.
15. Jakubowski H (2007) The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin Chem Lab Med 45 : 1704 1716.
16. Kloner RA, Rezkalla SH (2007) To drink or not to drink? That is the question. Circulation 116 : 1306 1317.
17. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ (2000) Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 20 (3 721 727.
18. Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES (2006) Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high- density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Metabolism 55 : 1201 1206.
19. Lewis JS, Achilefu S, Garbow JR, Laforest R, Welch MJ (2002) Small animal imaging. Current technology and perspectives for oncological imaging. Eur J Cancer 38 (16 2173 2188.
20. Mackness B, Durrington P, McElduff P, Yarnell J, Azam N, Watt M, Mackness M (2003) Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107 : 2775 2779.
21. Navab M, Berliner JA, Subbanagounder G, Hama S, Lusis AJ, Castellani LW, Reddy S, Shih D, Shi W, Watson AD, Van Lenten BJ, Vora D, Fogelman AM (2001) HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 21 : 481 488.
22. Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN (1997) Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio. J Clin Invest 99 : 2005 2019.
23. Rao MN, Marmillot P, Palmer DA, Seeff LB, Strader BD, Lakshman MR (2003) Light, but not heavy alcohol drinking stimulates paraoxonase by up regulating liver PON mRNA in both rats and humans. Metabolism 52 : 1287 1294.
24. Rosenblat M, Volkova N, Coleman R, Almagor Y, Aviram M (2008) Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. J Nutr Biochem 19 : 514 523.
25. Shih DM, Gu L, Hama S, Xia Y-R, Navab M, Fogelman AM, Luisis AJ (1996) Genetic-Dietary regulation of serum paraoxonase expression and its role in atherogenic mouse model. J Clin Invest 97 : 1630 1639.
26. Shih DM, Gu L, Xia Y-R, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394 : 284 287.
27. St Leger AS, Cochrane AL, Moore F (1979) Factors associated with cardiac mortality in developed countries with reference to the consumption of wine. Lancet 1 (8124 1017 1020.
28. Tangirala RK, Rubi EM, Palinski W (1995) Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 36 : 2320 2328.
29. Vigna GB, Costantini F, Aldini G, Carini M, Catapano A, Schena F, Tangerinia A, Bombardellie RE, Morazzonie P, Mezzettib A, Tangerini A, Zanca R, Bombardelli E, Morazzoni P, Fellina R, Facino RM (2003) Effect of Grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers. Metabolism 52 : 1250 1257.
30. Wiesmann F, Szimtenings M, Frydrychowicz A, Illinger R, Hunecke A, Rommel E, Neubauer S, Haase A (2003) High-resolution MRI with cardiac and respiratory gating allows for accurate in vivo atherosclerotic plaque visualization in the murine aortic arch. Magn Reson Med 50 (1 69 74.
31. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoproteins in atherogenesis. J Clin Invest 88 : 1785 1792.